Peter A LeWitt (Peter LeWitt)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Clinical Evaluation

Top Venues

Journal of neural transmission (Vienna, Austria : 1996)

Movement disorders : official journal of the Movement Disorder Society

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Peter A LeWitt, Glenn T Stebbins, Kenneth Vielsted Christensen, Riswanto Tan, Anél Pretorius, Mikael Thomsen
Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study. Movement disorders : official journal of the Movement Disorder Society 39 (3) (2024)
Peter A LeWitt, Luke Hong, Mark S Moehle
Anticholinergic drugs for parkinsonism and other movement disorders. Journal of neural transmission (Vienna, Austria : 1996) (2024)
Peter A LeWitt, Luke Hong, Mark S Moehle
Anticholinergic drugs for parkinsonism and other movement disorders. Journal of neural transmission (Vienna, Austria : 1996) (2024)
Peter A LeWitt, Glenn T Stebbins, Kenneth Vielsted Christensen, Riswanto Tan, Anél Pretorius, Mikael Thomsen
Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study. Movement disorders : official journal of the Movement Disorder Society 39 (3) (2024)
Peter A LeWitt, Glenn T Stebbins, Kenneth Vielsted Christensen, Riswanto Tan, Anél Pretorius, Mikael Thomsen
Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study. Movement disorders : official journal of the Movement Disorder Society (2024)
Fran Borovečki, Romana Perković, Norbert Kovacs, Peter A LeWitt, Monika Rudzinska Bar, Regina Katzenschlager
Are Parkinson's disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged? Journal of neural transmission (Vienna, Austria : 1996) (2023)
Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, Jennifer C Sasaki, René Meisner, Dolores Diaz, Hilda Solanoy, Xiang Wang, Elvira Negrou, Vitaliy V Bondar, Rajarshi Ghosh, Michael T Maloney, Nicholas E Propson, Yuda Zhu, Romeo D Maciuca, Laura Harris, Angela Kay, Peter A LeWitt, T Alex King, Drew Kern, Aaron Ellenbogen, Ira Goodman, Andrew Siderowf, Jason Aldred, Omid Omidvar, Shababa T Masoud, Sonnet S Davis, Annie Arguello, Anthony A Estrada, Javier de Vicente, Zachary K Sweeney, Giuseppe Astarita, Marie T Borin, Bradley K Wong, Harvey Wong, Hoang N Nguyen, Kimberly A Scearce-Levie, Carole Ho, Matthew D Troyer
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. Science translational medicine 14 (648) (2022)